With Up-to-$6.8M Grant, Spero Therapeutics to Advance Lead Candidate - Genetic Engineering & Biotechnology News

The Nation

With Up-to-$6.8M Grant, Spero Therapeutics to Advance Lead Candidate Genetic Engineering & Biotechnology News Spero Therapeutics said it has won up to $6.8 million from the Combating Antibiotic-Resistant Bacteria Accelerator (CARB-X) toward screening, identifying, and completing Phase I trials with at least one partner compound for the company's lead ... Tiny San Diego company wins top antibiotics awardThe San Diego Union-Tribune US–UK Alliance Targets World's Deadliest SuperbugsManaged Care magazine Quest for new antibiotics gets first major funding from global partnershipWashington Post CIDRAP -Healthcare Dive -BU Today -Becker's Hospital Review all 37 news articles »

from Health - Google News http://ift.tt/2nJqJlP